XML 39 R20.htm IDEA: XBRL DOCUMENT v3.19.1
Note 13 - Employee Equity Incentive Plans
12 Months Ended
Dec. 31, 2018
Notes to Financial Statements  
Disclosure of Compensation Related Costs, Share-based Payments [Text Block]
NOTE
13:
              
EMPLOYEE EQUITY INCENTIVE PLANS
 
Stock Option Plans
 
Description of
2016
Equity Incentive Plan
 
In
2016,
the Company’s Board of Directors and stockholders approved the OmniComm Systems, Inc.
2016
Equity Incentive Plan (the
“2016
Plan”). The
2016
Plan provides for granting Incentive Stock Options, Nonqualified Stock Options, Stock Appreciation Rights, Restricted Stock Awards, Phantom Stock Unit Awards and Performance Share Units. The
2016
Plan provides for the issuance of up to
10,000,000
shares of our common stock for issuance upon awards granted under the
2016
Plan. In addition, the number of shares of common stock available for issuance under the
2016
Plan shall automatically increase on
January
1st
of each year for a period of
nine
(
9
) years commencing on
January 1, 2017
and ending on (and including)
January 1, 2025,
in an amount equal to
five
percent (
5%
) of the total number of shares authorized under the
2016
Plan. Unless earlier terminated by the Board, the
2016
Plan shall terminate on
June 29, 2026.
As of
December 31, 2018,
11,025,000
shares were authorized under the
2016
Plan.
 
The maximum term for any option grant under the
2016
Plan is
ten
years from the date of the grant; however, options granted under the
2016
Plan will generally expire
five
years from the date of grant. Options granted under the
2016
Plan generally vest either upon grant or in
two
installments and
may
be conditioned on performance. Performance based options
may
be conditioned upon the attainment of revenue, EDITDA or other financial or performance goals of the Company. The
first
vesting, which is equal to
50%
of the granted stock options, usually occurs upon completion of
one
full year of employment from the date of grant and the
second
vesting usually occurs on the
second
anniversary of the date of grant. The vesting period typically begins on the date of hire for new employees and on the date of grant for existing employees. The restrictions on restricted shares granted under the
2016
Plan generally lapse in
three
equal annual installments on the anniversary of the date of grant. Any unvested stock options or restricted shares with restrictions that have
not
lapsed that are granted under the
2016
Plan are forfeited and expire upon termination of employment.
 
On
September 6, 2018,
the Company entered into restricted stock agreements (“RSAs”) with its Chief Executive Officer, Chief Financial Officer, Chief Operating Officer and Chief Technology Officer intended to provide incentive to the executives to ensure certain economic performance of the Company. The shares issuable under the RSAs were valued as of the grant date at
$0.33
per share. The RSAs provided for the issuance of up to
225,000
performance related shares of the Company's common stock to each of the executives provided certain milestones were met as follows: a) 
75,000
performance related shares are subject to individual performance. b) If the Company's
2018
Revenue equals or exceeds
$30
million and the Company’s
2018
EBITDA equals or exceeds
$6
million, the Company would award
75,000
 shares of common stock; c) If the Company's
2018
Revenue equals or exceeds
$32
million and the Company’s
2018
 EBITDA equals or exceeds
$7
million, the Company would award an additional
75,000
shares of common stock. The restrictions on
1/3
of the awarded performance shares will lapse on the first,
second
and
third
anniversaries of the 
2018
Annual Stockholder Meeting, which was held on
June 7, 2018.
Effective 
December 31, 2018
the Company had
not
 achieved the milestones relating to Revenue and EBITDA and therefore each of the Officers forfeited
150,000
of the
225,000
restricted shares that had been issued to each of them.
 
On
September 6, 2018,
the Company entered into restricted stock agreements (“RSAs”) with its Board of Directors intended to provide incentive to ensure certain economic performance of the Company. The shares issuable under the RSAs were valued as of the grant date at
$0.33
per share. The RSAs provided for the issuance of a total of
200,000
 restricted shares with the restrictions lapsing on the day prior to the the
2019
Annual Stockholder Meeting to each director. The RSAs include
75,000
performance related shares of the Company's common stock that are subject to the Company's
2018
Revenue equaling or exceeding
$30
million and the Company’s
2018
EBITDA equaling or exceeding
$6
million. Efeective 
December 31, 2018
the Company had
not
 achieved the milestones relating to Revenue and EBITDA and therefore each of the directors forfeited
75,000
of the
200,000
restricted shares that had been issued to each of them.
 
As of
December 31, 2018,
there were
2,395,000
outstanding options,
100,000
exercised options and
925,000
 restricted stock shares that have been granted under the
2016
Plan. At
December 31, 2018,
there were
7,605,000
shares available for grant as options or other forms of share-based compensation under the
2016
Plan.
 
Description of
2009
Equity Incentive Plan
 
In
2009,
the Company’s Board of Directors and stockholders approved the
2009
Equity Incentive Plan of OmniComm Systems, Inc. (the
“2009
Plan”). The
2009
Plan provided for granting Incentive Stock Options, Nonqualified Stock Options, Stock Appreciation Rights, Restricted Stock Awards, Phantom Stock Unit Awards and Performance Share Units. Pursuant to the
2009
Plan,
7,500,000
shares of the Company’s common stock were authorized for issuance.
 
The maximum term for any option grant under the
2009
Plan was
ten
years from the date of the grant; however, options granted under the
2009
Plan generally expired
five
years from the date of grant for most employees, officers and directors of the Company. Options granted under the
2009
Plan generally vested either upon grant or in
two
installments. The
first
vesting, which is equal to
50%
of the granted stock options, occurred upon completion of
one
full year of employment from the date of grant and the
second
vesting occurred on the
second
anniversary of the employee’s employment. The vesting period typically began on the date of hire for new employees and on the date of grant for existing employees. The restrictions on restricted shares granted under the
2009
 Plan generally lapsed in
three
equal annual installments on the anniversary of the date of grant. Any unvested stock options or restricted shares with restrictions that had 
not
lapsed that were granted under the
2009
 Plan were forfeited and expired upon termination of employment. The
2009
Plan was terminated upon the approval of the
2016
Plan.
No
further grants will be made under the
2009
Plan.
 
As of
December 31, 2018,
there were
175,000
outstanding options and
3,876,662
restricted stock shares that have been granted under the
2009
Plan. At
December 31, 2018,
there were -
0
- shares available for grant as options or other forms of share-based compensation under the
2009
Plan.
 
The following table summarizes the stock option activity for the Company’s equity incentive plans:
 
   
Number of
options
   
Weighted average
exercise price
(per share)
   
Weighted average
remaining
contractual term
(in years)
   
Aggregate
intrinsic value
 
                                 
Outstanding at December 31, 2016
   
1,225,000
    $
0.17
     
2.62
    $
83,425
 
Granted
   
4,650,000
     
0.26
     
 
     
 
 
Exercised
   
(300,000
)    
0.13
     
 
     
 
 
Forfeited/cancelled/expired
   
(300,000
)    
0.14
     
 
     
 
 
                                 
Outstanding at December 31, 2017
   
5,275,000
     
0.26
     
4.09
    $
130,475
 
Granted
   
570,000
     
0.28
     
 
     
 
 
Exercised
   
(300,000
)    
0.21
     
 
     
 
 
Forfeited/cancelled/expired
   
(2,975,000
)    
0.25
     
 
     
 
 
                                 
Outstanding at December 31, 2018
   
2,570,000
    $
0.28
     
3.47
    $
16,675
 
                                 
                                 
Vested and exercisable at December 31, 2018
   
887,500
    $
0.25
     
2.92
    $
14,425
 
 
 
The aggregate intrinsic value in the table above represents the total intrinsic value (the difference between the Company’s closing stock price at fiscal year-end and the exercise price, multiplied by the number of in-the-money options) that would have been received by the option holders had all option holders exercised their options on
December 31, 2018.
 
The total number of shares vested and the fair value of shares vested for the years ended
December 31, 2018
and
December 31, 2017,
respectively, was:
 
Fair value of options vesting
for the year ended
 
Number of options
vested
   
Fair value of
options vested
 
December 31, 2018
   
812,500
    $
179,978
 
December 31, 2017
   
62,500
    $
12,742
 
 
 
Cash received from stock option exercises for the year ended
December 31, 2018
was
$45,000
and
$35,250
for the year ended 
December 31, 2017. 
Due to the Company’s net loss position,
no
income tax benefit has been realized during the years ended
December 31, 2018
and
December 31, 2017.
 
The following table summarizes information concerning options outstanding at
December 31, 2018:
 
Awards breakdown by price range at December 31, 2018
 
 
 
 
 
 
Outstanding
   
Vested
 
Strike price
range ($)
   
Outstanding
stock options
   
Weighted
average
remaining
contractual life
   
Weighted
average
outstanding
strike price
   
Vested stock
options
   
Weighted
average
remaining
vested
contractual life
   
Weighted
average vested
strike price
 
0.00
to
0.20
     
150,000
     
0.93
    $
0.17
     
150,000
     
0.93
    $
0.17
 
0.21 
to
0.30
     
1,695,000
     
3.54
     
0.26
     
550,000
     
3.15
     
0.25
 
0.31 
to
0.50
     
725,000
     
3.82
     
0.34
     
187,500
     
3.82
     
0.34
 
0.00 
to
0.50
     
2,570,000
     
3.47
    $
0.28
     
887,500
     
2.92
    $
0.25
 
 
 
The following table summarizes information concerning options outstanding at
December 31, 2017:
 
Awards breakdown by price range at December 31, 2017
 
 
 
 
 
 
Outstanding
   
Vested
 
Strike price
range ($)
   
Outstanding
stock options
   
Weighted
average
remaining
contractual life
   
Weighted
average
outstanding
strike price
   
Vested stock
options
   
Weighted
average
remaining
vested
contractual life
   
Weighted
average vested
strike price
 
0.00 
to
0.20
     
300,000
     
1.93
    $
0.18
     
250,000
     
1.48
    $
0.17
 
0.21 
to
0.30
     
4,250,000
     
4.12
     
0.25
     
150,000
     
1.30
     
0.22
 
0.31 
to
0.50
     
725,000
     
4.82
     
0.34
     
-0-
     
0.00
     
0.00
 
0.00 
to
0.50
     
5,275,000
     
4.09
    $
0.26
     
400,000
     
1.42
    $
0.19
 
 
 
The weighted average fair value (per share) of options granted during the year ended
December 31, 2018
was
$0.23
 and
$0.21
 for the year ended
December 31, 2017
using the Black Scholes option-pricing model.
 
Basis for Fair Value Estimate of Share-Based Payments
 
Based on analysis of its historical volatility, the Company expects that the future volatility of its share price is likely to be similar to the historical volatility the Company experienced since the Company’s commercialization activities were initiated during the
second
half of
2000.
The Company used a volatility calculation utilizing the Company’s own historical volatility to estimate its future volatility for purposes of valuing the share-based payments granted during fiscal
2018
and
2017.
Actual volatility, and future changes in estimated volatility,
may
differ substantially from the Company’s current estimates.
 
The Company utilizes the historical data available regarding employee and director exercise activity to calculate an expected life of the options. The table below presents the weighted average expected life in years of options granted under the Plan as described above. The risk-free rate of the stock options is based on the U.S. Treasury yield curve in effect at the time of grant, which corresponds with the expected term of the option granted.
 
The fair value of share-based payments was estimated using the Black Scholes option pricing model with the following assumptions for grants made during the periods indicated.
 
   
Stock option assumptions for the period ended
 
Stock option assumptions
 
December 31, 2018
   
December 31, 2017
 
Risk-free interest rate
   
2.91%
     
1.81%
 
Expected dividend yield
   
0.0%
     
0.0%
 
Expected volatility
   
111.0%
     
127.1%
 
Expected life of options (in years)
   
5
     
5
 
 
 
The following table summarizes weighted average grant date fair value for the Company incentive stock plans:
 
   
Weighted average grant date fair value
 
   
for the year ended December 31,
 
   
2018
   
2017
 
Stock options granted during the period
  $
0.23
    $
0.21
 
                 
Stock options vested during the period
  $
0.22
    $
0.20
 
                 
Stock options forfeited during the period
  $
0.19
    $
0.13
 
 
 
 
 
A summary of the status of the Company’s non-vested shares underlying stock options as of
December 31, 2018,
and changes during the year ended
December 31, 2018
is as follows:
 
   
Shares underlying stock
options
   
Weighted average grant
date fair value
 
Nonvested shares at January 1, 2018
   
4,875,000
    $
0.21
 
                 
Nonvested shares at December 31, 2018
   
1,682,500
    $
0.24
 
 
As of
December 31, 2018,
approximately
$267,766
 of total unrecognized compensation cost related to unvested stock options is expected to be recognized over a weighted-average period of
1.88
years.